Hosking Partners’s Atlanta Braves Holdings Series B BATRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,981
Closed -$276K 116
2023
Q4
$276K Sell
6,981
-529
-7% -$19.3K 0.01% 110
2023
Q3
$268K Buy
+7,510
New +$284K 0.01% 110
2023
Q1
Sell
-6,238
Closed -$201K 146
2022
Q4
$201K Buy
+6,238
New +$194K 0.01% 137
2022
Q3
Sell
-3,744
Closed -$90K 154
2022
Q2
$90K Buy
+3,744
New +$94.6K ﹤0.01% 157
2018
Q4
Sell
-7,758
Closed -$211K 171
2018
Q3
$211K Sell
7,758
-279
-3% -$7.27K ﹤0.01% 175
2018
Q2
$208K Buy
+8,037
New +$194K ﹤0.01% 172
2018
Q1
Sell
-29,504
Closed -$656K 176
2017
Q4
$656K Buy
29,504
+1,920
+7% +$45K 0.02% 168
2017
Q3
$697K Buy
27,584
+355
+1% +$8.76K 0.02% 164
2017
Q2
$653K Sell
27,229
-12,137
-31% -$290K 0.02% 164
2017
Q1
$931K Buy
39,366
+3,339
+9% +$71.3K 0.03% 161
2016
Q4
$742K Sell
36,027
-932
-3% -$17.4K 0.02% 160
2016
Q3
$642K Sell
36,959
-15,399
-29% -$250K 0.02% 156
2016
Q2
$768K Buy
+52,358
New +$781K 0.03% 150

Other funds holding BATRK

Hosking Partners's BATRK Position: Q1 2024 in Review

Hosking Partners sold out of Atlanta Braves Holdings Series B (BATRK) in Q1 2024, closing a stake of 6,981 shares — an estimated $276K sold.

Hosking Partners first reported a position in BATRK in Q2 2016 and held it in 13 quarters. The position peaked at $931K in Q1 2017. 271 funds tracked by Wall St. Rank hold BATRK as of Q1 2024.

  • Hosking Partners reported no remaining Atlanta Braves Holdings Series B position as of Q1 2024 after selling out during the quarter.
  • Hosking Partners sold 6,981 Atlanta Braves Holdings Series B shares in Q1 2024, an estimated $276K.
  • Hosking Partners first reported a position in Atlanta Braves Holdings Series B in Q2 2016 and held it in 13 quarters.
  • Hosking Partners's Atlanta Braves Holdings Series B position peaked at $931K in Q1 2017.
  • 271 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series B as of Q1 2024.

Based on Hosking Partners's 13F filing for Q1 2024, filed 2 May 2024.